Anaemia in pregnancy

Clinical Study of Iron Deficiency Anaemia in Pregnancy (Adam-e-Damviat Douran-e-Hamal) and its Management With Unani Drug - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/066525

Enrollment

Registered

2024-04-30

Start date

Unknown

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O990- Anemia complicating pregnancy, childbirth and the puerperium

Interventions

Intervention1: Sharbat e Unnab: Oral Administration of Sharbat e Unnab 10ml Morning and Evening for 3 months Control Intervention1: Not Applicable: Not Applicable

Eligibility

Inclusion criteria

Inclusion criteria: Both Primi and Multi Gravidae Between Gestational Age 20 Weeks-32 Weeks. Hb% Levels Between 8g/dl-10g/dl

Exclusion criteria

Exclusion criteria: Patients With Severe Oligohydramnios Patients Having Systematic Diseases Such as Diabetes Mellitus, Hypertension, Renal Disorders, Cardiac Disorders, Haemolytic Disorders, Malignancy and Tumors

Design outcomes

Primary

Measure	Time frame
To Minimize The Maternal and Fetal complications in Anaemia During PregnancyTimepoint: Each Patient outcomes Depends After 3 Months of Oral Administration	—

Secondary

Measure	Time frame
To Evaluate the Effect of Unani Drug To Increase The Haemoglobin level To Increase The Serum Ferritin valueTimepoint: Each Patient outcomes Depends after 3 Months of Oral Administration	—

Countries

India

Contacts

Public ContactDr A Suhasini

Govt. Nizamia Tibbi College and General Hospital

drasuhasini12@gmail.com9949586899

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026